Literature DB >> 14527493

Stress and epilepsy: a patient perception survey.

Sheryl R Haut1, Mary Vouyiouklis, Shlomo Shinnar.   

Abstract

A questionnaire was administered to patients in the Montefiore Medical Center outpatient epilepsy department to assess perceptions about stress, seizures, and stress reduction. Eighty-nine patients completed the questionnaire. Overall, 64% of patients reported the belief that stress increased the frequency of their seizures. This belief was not significantly associated with gender, age, location of care, epilepsy classification, or seizure control, but was significantly associated with a shorter duration of epilepsy (P=0.04). Thirty-two percent of subjects had tried stress reduction modalities for epilepsy. Of those who had not, 53% were willing to try, and this willingness was significantly associated with a greater number of seizures in the prior 2 months (P=0.006) and the belief that stress was associated with seizures (P=0.04). Both major and minor stressors were reported with equal frequency. The majority of our study population believe that stress and seizures are related, and are willing to try stress reduction techniques for seizure control. We believe that these findings indicate a need for a prospective study to evaluate the role of stress and stress reduction as an additional potential therapeutic modality for epilepsy.

Entities:  

Mesh:

Year:  2003        PMID: 14527493     DOI: 10.1016/s1525-5050(03)00182-3

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  20 in total

1.  Seizure susceptibility and epileptogenesis in a rat model of epilepsy and depression co-morbidity.

Authors:  S Alisha Epps; Kroshona D Tabb; Sharon J Lin; Alexa B Kahn; Martin A Javors; Katherine A Boss-Williams; Jay M Weiss; David Weinshenker
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

2.  Lennox-lombroso lecture, 2013: psychiatric comorbidities through the life of the seizure disorder: a complex relation with a not so complex solution.

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2014 Nov-Dec       Impact factor: 7.500

Review 3.  Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy.

Authors:  Aynara C Wulsin; Matia B Solomon; Michael D Privitera; Steve C Danzer; James P Herman
Journal:  Physiol Behav       Date:  2016-05-16

Review 4.  Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.

Authors:  Jamie Maguire; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2012-11-29       Impact factor: 2.937

Review 5.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

6.  Seizure-induced disinhibition of the HPA axis increases seizure susceptibility.

Authors:  Kate K O'Toole; Andrew Hooper; Seth Wakefield; Jamie Maguire
Journal:  Epilepsy Res       Date:  2013-10-28       Impact factor: 3.045

7.  Evaluation of mediators of change in the treatment of epilepsy with acceptance and commitment therapy.

Authors:  Tobias Lundgren; JoAnne Dahl; Steven C Hayes
Journal:  J Behav Med       Date:  2008-03-06

8.  Scn8a voltage-gated sodium channel mutation alters seizure and anxiety responses to acute stress.

Authors:  Nikki T Sawyer; Ligia A Papale; Jessica Eliason; Gretchen N Neigh; Andrew Escayg
Journal:  Psychoneuroendocrinology       Date:  2013-09-24       Impact factor: 4.905

9.  Engaging stakeholders in the refinement of an evidence-based remotely delivered epilepsy self-management program for rural populations.

Authors:  Carol Blixen; Gena Ghearing; Owen Wade; Kari Colon-Zimmerman; Maegan Tyrrell; Martha Sajatovic
Journal:  Epilepsy Behav       Date:  2021-04-10       Impact factor: 2.937

Review 10.  Cycles in epilepsy.

Authors:  Philippa J Karoly; Vikram R Rao; Maxime O Baud; Nicholas M Gregg; Gregory A Worrell; Christophe Bernard; Mark J Cook
Journal:  Nat Rev Neurol       Date:  2021-03-15       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.